The effect of delaying nephrectomy on oncologic outcomes in patients with renal tumors greater than 4cm.

[1]  R. Uzzo,et al.  Growth kinetics and short-term outcomes of cT1b and cT2 renal masses under active surveillance. , 2014, The Journal of urology.

[2]  K. Chamie,et al.  Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage. , 2012, The Journal of urology.

[3]  Choung-Soo Kim,et al.  The impact of delaying radical nephrectomy for stage II or higher renal cell carcinoma , 2012, Journal of Cancer Research and Clinical Oncology.

[4]  J. Cheville,et al.  Metastatic potential of a renal mass according to original tumour size at presentation , 2012, BJU international.

[5]  B. Ljungberg,et al.  Metastatic potential in renal cell carcinomas ≤7 cm: Swedish Kidney Cancer Quality Register data. , 2011, European urology.

[6]  A. Evans,et al.  Active surveillance of small renal masses: progression patterns of early stage kidney cancer. , 2011, European urology.

[7]  L. Klotz,et al.  Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance. , 2011, European urology.

[8]  U. Dafni.  Landmark Analysis at the 25-Year Landmark Point , 2011, Circulation. Cardiovascular quality and outcomes.

[9]  C. Ko,et al.  Wait Times for Cancer Surgery in the United States: Trends and Predictors of Delays , 2011, Annals of surgery.

[10]  J. Chin,et al.  How long can patients with renal cell carcinoma wait for surgery without compromising pathological outcomes? , 2011, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[11]  Lorenzo Marconi,et al.  EAU guidelines on renal cell carcinoma: 2014 update. , 2010, European urology.

[12]  Adam C. Mues,et al.  Active surveillance for larger (cT1bN0M0 and cT2N0M0) renal cortical neoplasms. , 2010, Urology.

[13]  N. Haseke,et al.  The growth rate of large renal masses opposes active surveillance , 2010, BJU international.

[14]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[15]  A. Laupacis,et al.  Longer wait times increase overall mortality in patients with bladder cancer. , 2009, The Journal of urology.

[16]  J. Bellmunt.  Faculty Opinions recommendation of Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis. , 2009 .

[17]  L. Kavoussi,et al.  Incidentally discovered renal masses: oncological and perioperative outcomes in patients with delayed surgical intervention , 2009, BJU international.

[18]  J. Gore,et al.  Mortality increases when radical cystectomy is delayed more than 12 weeks , 2009, Cancer.

[19]  S. Herrell,et al.  Waiting time from initial urological consultation to nephrectomy for renal cell carcinoma--does it affect survival? , 2008, The Journal of urology.

[20]  R. Uzzo,et al.  Delayed intervention of sporadic renal masses undergoing active surveillance , 2008, Cancer.

[21]  Antonio Lopez-Beltran,et al.  2004 WHO classification of the renal tumors of the adults. , 2006, European urology.

[22]  R. Dunn,et al.  Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival. , 2006, The Journal of urology.

[23]  A. Hanlon,et al.  The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. , 2006, The Journal of urology.

[24]  P. Vasey,et al.  Management of renal masses in patients medically unsuitable for nephrectomy--natural history, complications, and outcome. , 2004, Urology.

[25]  J. Cheville,et al.  Solid renal tumors: an analysis of pathological features related to tumor size. , 2003, The Journal of urology.

[26]  B. Donnelly,et al.  Does prolonging the time to renal cancer surgery affect long-term cancer control: a systematic review of the literature. , 2006, The Canadian journal of urology.

[27]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.